With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU).
Avec cet élargissement d’indication, IXCHIQ®, le premier vaccin autorisé au monde contre le virus du chikungunya (CHIKV), est désormais disponible pour une administration dans l'Union Européenne (UE) ...
Stride Expands Across the Midwest, Celebrating its Tenth Center in Iowa and Sixth in Nebraska ...
Omega Laboratories of Ohio, USA, recently announced the development and validation of the Cannabix Marijuana Breath Test; The ...
MISSISSAUGA, Ontario, 01 avr. 2025 (GLOBE NEWSWIRE) -- Le Collège des médecins de famille du Canada (CMFC) exhorte les partis politiques fédéraux à prendre des mesures visant à protéger et renforcer l ...
The company’s Freedom Alert Max, its latest medical alert innovation, has secured approval to be procured through the U.S. General Services Administration (GSA). This approval empowers agencies, ...
MISSISSAUGA, Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- The College of Family Physicians of Canada (CFPC) is calling on all federal political parties to commit to actions that protect and strengthen ...
Genetic Networks, a wholly owned subsidiary of Fifty 1 Labs, Inc., specializes in genetic profiling and bioinformatics, delivering transformative insights into biological systems. Led by experts like ...
A webcast of the presentation will be available on the “ Events ” section of the Clene website. Alternatively, one can register online to view the webcast here: link ...
InfiniSurg, LLC is recognized for its patient-centric approach and commitment to innovation in outpatient surgical care. The addition of CompuFlo® reflects InfiniSurg’s focus on leveraging advanced ...
Interim results demonstrate GRI-0621 to be safe and well-tolerated in the first 12 patients evaluated Interim biomarker data on track for Q2 2025 and topline results expected Q3 2025 Currently ...